Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| adipocyte | 8 studies | 46% ± 12% | |
| endothelial cell | 4 studies | 19% ± 3% | |
| endothelial cell of lymphatic vessel | 3 studies | 23% ± 7% |
Insufficient scRNA-seq data for expression of GABRE at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| uterus | 98% | 3745.18 | 167 / 170 | 77% | 26.39 | 354 / 459 |
| pancreas | 93% | 1672.92 | 305 / 328 | 80% | 14.36 | 143 / 178 |
| lung | 99% | 3022.67 | 571 / 578 | 69% | 17.41 | 794 / 1155 |
| bladder | 95% | 4219.14 | 20 / 21 | 72% | 17.06 | 364 / 504 |
| intestine | 79% | 1935.94 | 763 / 966 | 72% | 9.73 | 381 / 527 |
| thymus | 99% | 3963.95 | 649 / 653 | 51% | 4.61 | 309 / 605 |
| ovary | 77% | 1688.51 | 139 / 180 | 72% | 12.05 | 308 / 430 |
| esophagus | 84% | 3530.99 | 1210 / 1445 | 63% | 21.77 | 116 / 183 |
| prostate | 100% | 9554.98 | 244 / 245 | 44% | 3.93 | 220 / 502 |
| kidney | 81% | 1660.22 | 72 / 89 | 46% | 5.97 | 416 / 901 |
| breast | 100% | 8946.16 | 459 / 459 | 26% | 3.00 | 291 / 1118 |
| skin | 99% | 4235.53 | 1785 / 1809 | 3% | 0.22 | 14 / 472 |
| adipose | 100% | 10868.50 | 1204 / 1204 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 100% | 3.10 | 1 / 1 |
| spleen | 97% | 2326.75 | 234 / 241 | 0% | 0 | 0 / 0 |
| blood vessel | 96% | 2692.96 | 1283 / 1335 | 0% | 0 | 0 / 0 |
| stomach | 40% | 717.48 | 145 / 359 | 55% | 8.82 | 157 / 286 |
| heart | 90% | 2067.97 | 775 / 861 | 0% | 0 | 0 / 0 |
| liver | 31% | 436.85 | 71 / 226 | 55% | 6.39 | 224 / 406 |
| tonsil | 0% | 0 | 0 / 0 | 84% | 15.94 | 38 / 45 |
| adrenal gland | 61% | 806.21 | 157 / 258 | 17% | 2.20 | 38 / 230 |
| brain | 9% | 290.05 | 244 / 2642 | 8% | 0.88 | 56 / 705 |
| muscle | 7% | 77.36 | 54 / 803 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| peripheral blood | 0% | 0 | 0 / 929 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_2001226 | Biological process | negative regulation of chloride transport |
| GO_1904862 | Biological process | inhibitory synapse assembly |
| GO_1902476 | Biological process | chloride transmembrane transport |
| GO_0060078 | Biological process | regulation of postsynaptic membrane potential |
| GO_0051932 | Biological process | synaptic transmission, GABAergic |
| GO_0007214 | Biological process | gamma-aminobutyric acid signaling pathway |
| GO_0005886 | Cellular component | plasma membrane |
| GO_1902495 | Cellular component | transmembrane transporter complex |
| GO_0098794 | Cellular component | postsynapse |
| GO_0043005 | Cellular component | neuron projection |
| GO_0034707 | Cellular component | chloride channel complex |
| GO_0045202 | Cellular component | synapse |
| GO_0045211 | Cellular component | postsynaptic membrane |
| GO_1902711 | Cellular component | GABA-A receptor complex |
| GO_0032590 | Cellular component | dendrite membrane |
| GO_0004890 | Molecular function | GABA-A receptor activity |
| GO_0005254 | Molecular function | chloride channel activity |
| GO_0022851 | Molecular function | GABA-gated chloride ion channel activity |
| GO_0008503 | Molecular function | benzodiazepine receptor activity |
| Gene name | GABRE |
| Protein name | Gamma-aminobutyric acid receptor subunit epsilon (GABA(A) receptor subunit epsilon) Gamma-aminobutyric acid type A receptor subunit epsilon |
| Synonyms | |
| Description | FUNCTION: GABA, the major inhibitory neurotransmitter in the vertebrate brain, mediates neuronal inhibition by binding to the GABA/benzodiazepine receptor and opening an integral chloride channel. |
| Accessions | F2Z2H5 P78334 ENST00000370328.4 [P78334-1] ENST00000417300.1 ENST00000441219.5 |